Jenner

6 July 2010	Prof Paul Griftiths, Centre for Virology, University College London Medical School Progress towards vaccines against human cytomegalovirus
4 June 2010	Prof Mary Collins, Dean of the Faculty of Life Sciences, University College London Regulating dendritic cell signalling to improve vaccination
18 May 2010	Prof Glyn Hewinson, Veterinary Laboratories Agency TB Vaccines for Badgers and Cattle: No More Mr. Ten Years!
20 April 2010	Prof Paul Fine, Professor of Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine Vaccines, herd immunity and eradication programmes
16 Mar 2010	Prof Andy Morgan, Department of Cellular & Molecular Medicine, University of Bristol Progress in the development of vaccines for Epstein-Barr virus and its associated diseases
14 Jan 2010	Dr Ed Lavelle, School of Biochemistry & Immunology, Trinity College Dublin Particulate adjuvants for parenteral and mucosal vaccines
16 Oct 2009	Assoc. Prof Dan Barouch, Chief, Division of Vaccine Research, Harvard University Novel Vectors and Antigens for an HIV Vaccine
21 Sept 2009	Dr Marie-Paule Kieny, Director, WHO Initiative for Vaccine Research Vaccine Research and International Health
19 Aug 2009	Prof Ian Orme, Colorado State University, College of Veterinary Medicine & Biomedical Sciences TB: Two scary stories and one marginally disturbing...
14 July 2009	Prof Mark Kendall, University of Queensland, Australian Institute for Bioengineering and Nanotechnology Nanopatches: targeted delivery to skin for improved vaccines
16 June 2009	Prof Paul Kaye, University of York, Centre for Immunology and Infection Therapeutic vaccines for leishmaniasis: lessons from pathology
12 May 2009	Prof Alan Rickinson, University of Birmingham, School of Cancer Sciences Prospects for therapeutic vaccines against Epstein-Barr virus-associated tumours
21 April 2009	Dr Satya Parida, Institute for Animal Health, FMD Vaccine Differentiation Group Vaccination against FMDV: strategies and effectiveness
17 March 2009	Prof Sarah Rowland-Jones (MRC and Weatherall Institute for Molecular Medicine, University of Oxford) What can HIV-2 teach us about protective immunity in HIV infection?
13 Jan 2009	Dr Dirk Werling (Royal Veterinary College, Dept. of Pathology & Infectious Diseases) Structure-function relationships of Toll-like receptor domains in different species and their potential impact on vaccine design
7 Oct 2008	Dr Rachel Midgley (Clinical Director, Oncology Clinical Trials Office, Department of Clinical Pharmacology, University of Oxford) Cancer Vaccines - Principles and Practice
9 Sept 2008	Prof Albert Osterhaus (Head of Department of Virology, Erasmus MC, University of Rotterdam) Influenza Vaccines
26 Aug 2008	Dr David Lewinsohn (Asst. Professor, Oregon Health & Science University, Molecular Microbiology and Immunology) Recognition of Intracellular Infection with Mtb: The Human CD8 Response to Tuberculosis
17 June 2008	Dr Robert Harrison (Head, Alistair Reid Venom Research Unit, Liverpool School of Tropical Medicine) New strategies to improve an old therapy - snake antivenom
8 July 2008	Prof John Hermon-Taylor (School of Biomedical and Health Sciences, King's College London) A tutorial on paratuberculosis: New insights into human disease
20 May 2008	Prof Dave Stuart (MRC Professor of Structural Biology, Division of Structural Biology, Henry Wellcome Building for Genomic Medicine, University of Oxford) Foot and mouth disease virus - structure and vaccine design"
8 April 2008	Prof Declan McKeever (Chair of Immunoparasitology and Head of Pathology & Infectious Diseases, Royal Veterinary College)
19 Feb 2008	Dr Paul Klenerman (Wellcome Trust Senior Fellow, Peter Medawar Building for Pathogen Research, University of Oxford) HCV Vaccines - Demand and Supply
22 Jan 2008	Prof Jonathan Heeney (Comparative Pathology, University of Cambridge) "What Jenner didn't know": Poxviruses which differentially induce CD4 or CD8 T-cells and immunity
11 Dec 2007	Dr John Shiver (Vice President Vaccines and Biologics Research, Merck & Co. Inc.) Merck's HIV Vaccine Programme
6 Nov 2007	Prof Mark Stephens (IAH) Toward control of food-borne diarrhoeal pathogens
2 Oct2007	Prof John Oxford, Oxford Volunteers for influenza quarantine experiments: from the 1918 pandemic
26 Jun 2007	Dr Lucy Dorrell, Compton Therapeutic HIV vaccines
29 May 2007	Dr Venugopal Nair, Oxford Marek's disease: a natural lymphoma controlled by vaccination
24 Apr 2007	Dr Linda Dixon, Oxford Strategies to produce African swine fever vaccines
13 Mar 2007	Prof Richard Moxon, Compton The challenge of the meningococcus
27 Feb 2007	Dr Tom Barrett, Oxford Rinderpest and PPR vaccines: how can they be improved?
23 Jan 2007	Dr Sarah Gilbert, Compton Replication-deficient viral vaccines
13 Dec 2006	Prof Andrew McMichael, Compton HIV vaccine design
12 Dec 2006	Dr Adrian Smith, Oxford Protective immunity to intracellular infection in the gut: where, how and what is important?
21 Nov 2006	Prof Vincenzo Cerundolo, Compton Harnessing NKT cells in vaccination strategies
24 Oct 2006	Dr Jayne Hope, Oxford Dendritic cells and immune responses to bovine TB
21 Sep 2006	Dr Tomas Hanke, Compton HIV vaccine development
02 May 2006	Prof Quentin Sattentau, Compton The role of reactive carbonyls in vaccine hypersensitivity
11 Apr 2006	Dr Helen McShane, Compton Developing a better TB vaccine: clinical trials with MVA85A
04 Apr 2006	Dr Jim Kaufman, Oxford Avian influenza: the bird’s eye view
14 Mar 2006	Dr Andrew Pollard, Compton B cell responses to conjugate vaccines in infants
07 Mar 2006	Dr Geraldine Taylor, Oxford Bovine RSV vaccines
14 Feb 2006	Martin Maiden, Compton Vaccines against meningococcal disease
07 Feb 2006	Dr David Paton & Dr Bryan Charleston, Oxford Foot and mouth disease virus: strategies to improve vaccines
08 Nov 2005	Prof Adrian Hill, Compton Developing malaria vaccines: bench to bush
01 Nov 2005	Sir Gustav Nossal (Opening Symposium), Oxford Developing country health post-Gleneagles

Back